The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has said it will launch a pilot programme in the coming weeks to see how it can evolve the regulation of artificial ...
including rAAV8.hRKp.AIPL1 for LCA4 - Received from HPRA and MHRA additional clinical and commercial licensures in Ireland and UK for Shannon and London GMP viral vector manufacturing facilities ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for nemolizumab to treat moderate-to-severe prurigo nodularis in adults and moderate-to-severe ...
Hosted on MSN11mon
iECURE receives FDA IND clearance for OTC deficiency treatment trialECUR-506 utilises a two-vector system: an ARCUS nuclease vector ... from the Medicines and Healthcare Products Regulatory Agency (MHRA) and in Australia by the Therapeutic Goods Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback